![\"memory](\"https:\/\/fomatmedical.com\/wp-content\/uploads\/2019\/08\/alzheimer-disease-loss-of-memory-photo-of-older-lady-wth-memory-issues-1-300x169.webp\" "\\"|\\"")
<\/p>\nHow memories form and fade has been one of the most fundamental questions in neuroscience. Why can you recall the name of a childhood best friend you have not seen in decades, yet forget the name of someone you met just moments ago? Researchers at the California Institute of Technology have now produced findings that help answer this question, with important implications for understanding conditions like Alzheimer’s disease and age related memory loss.<\/p>\n
The Caltech research, published in the journal Science, was conducted using mouse models in the laboratory of Carlos Lois, a research professor of biology. Led by postdoctoral scholar Walter Gonzalez, the team developed a test to examine neural activity as mice learned about and remembered a new environment.<\/p>\n
Mice were placed in a straight enclosure approximately five feet long, with unique symbols marking different locations along the walls. Sugar water was placed at either end as a reward. As the mice explored, researchers measured activity in the hippocampus, the region of the brain responsible for forming new memories.<\/p>\n
When a mouse was first placed in the enclosure, single neurons fired in response to each symbol. But as the animal became more familiar with the environment and learned where the sugar was located, more and more neurons activated together in synchrony in response to each symbol. The key finding was that strong, stable memories were encoded not by individual neurons but by teams of neurons firing simultaneously, providing a layer of redundancy that allows memories to persist over time.<\/p>\n
To study how memories fade, the researchers kept the mice away from the track for up to 20 days. When the animals returned, those that had formed stronger memories encoded by larger groups of neurons remembered the task quickly, even if some of the individual neurons showed different patterns of activity. The group encoding provided enough overlap and redundancy that the memory remained intact.<\/p>\n
This offers a direct explanation for how memories form and fade differently depending on how deeply they are encoded. A memory tied to a single neuron is fragile. If that neuron is damaged or falls silent, the memory is lost. A memory distributed across many neurons is far more resilient, because the loss of any one element does not erase the whole.<\/p>\n
Gonzalez described it this way: imagine you have a long and complicated story to tell. To preserve it, you share it with five friends and occasionally get together to retell it, helping each other fill in gaps. Each time you retell the story, new friends join and learn it too. Your neurons work in an analogous way, helping each other encode memories that will endure over time.<\/p>\n
<\/p>\n
The research has significant implications for understanding how memory is affected by aging and disease. Memory loss associated with normal aging may occur in part because memories come to be encoded by fewer neurons over time. When any of those neurons fail, the memory disappears entirely. The same mechanism may help explain the more severe memory deterioration seen in Alzheimer’s disease and following brain damage from strokes.<\/p>\n
“For years, people have known that the more you practice an action, the better chance that you will remember it later,” said Lois. “We now think this is likely because the more you practice, the higher the number of neurons encoding the action.”<\/p>\n
The study raises the possibility that future treatments could focus on boosting the recruitment of additional neurons during memory formation, potentially offering a new pathway for preventing or slowing memory loss. Understanding how memories form and fade at the neurological level is the essential first step toward developing those interventions.<\/p>\n
Advancing treatments for conditions like Alzheimer’s disease requires not only laboratory breakthroughs but also robust clinical trial infrastructure to test those discoveries in human populations. FOMAT supports sponsors and CROs in conducting Phase I through Phase IV studies across a range of therapeutic areas, including neurology. Our investigator network across the United States provides access to diverse patient populations and experienced research teams capable of executing complex studies efficiently.<\/p>\n
To learn more about our active studies<\/a> or our clinical trial capabilities<\/a>, visit fomatmedical.com.<\/p>\n To read the original Caltech research, click here<\/a><\/p>\nFor More Information<\/h4>\n